Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A.
Guadalupi L, et al. Among authors: mariani f.
Neuropharmacology. 2024 Apr 2;252:109940. doi: 10.1016/j.neuropharm.2024.109940. Online ahead of print.
Neuropharmacology. 2024.
PMID: 38570068
Free article.